Classes
DEA Class; Rx
Common Brand Names; Rezira
- Antitussives, Narcotic Combos
Description
Oral opiate agonist antitussive and decongestant combination
Used to suppress cough and relieve congestion associated with the common cold or other upper respiratory infections
Contraindicated in pediatric patients
Indications
Contraindications
Hydrocodone
Absolute: acute abdominal condition, diarrhea associated with toxins, paralytic ileus, pseudomembranous colitis, respiratory depression
Relative: asthma (acute), cardiac arrhythmia, cardiac disease, congestive heart failure, coronary artery DX, bladder outlet obstruction, GI tract obstruction, glaucoma (open & closed), hemorrhage, hiatal hernia, inflammatory bowel disease, intestinal atony, mitral valve stenosis, myasthenia gravis, obstructive uropathy, prostatic hypertrophy, reflux esophagitis, respiratory impairment, tachycardia, ulcerative colitis, urinary retention
Pseudoephedrine
Hypsesensitivity
Severe HTN, severe CAD
Nonselective MAO inhibitors: risk of hypertensive reaction
Newborns, preemies
Adverse Effects
Hydrocodone
Bradycardia, anticholinergic effects (dry mouth, palpitation, tachycardia)
Angina, arrhythmias, cardiac arrest, myocardial infarction, QT-interval prolongation, pectoris, syncope, severe cardiac ST segment elevation, ventricular tachycardia
Agitation, coma, dizziness, mental clouding/depression, dysphoria, euphoria, faintness, restlessness, nervousness, weakness, sedation, seizures, visual disturbances
Flushing, sweating, pruritus, urticaria, warmness of the face/neck/upper thorax
Constipation, nausea, vomiting
Urinary retention, oliguria
Respiratory/circulatory depression, respiratory arrest, shock, cardiac arrest
Pseudoephedrine
CNS (tremor, restlessness, etc)
Insomnia
Nausea
Vomiting
Warnings
Hydrocodone
Concomitant use of opioids with benzodiazepines, or other CNS depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death; avoid use of opioid cough medications in patients taking benzodiazepines, other CNS depressants, or alcohol
Concomitant use of opioid analgesics and benzodiazepines increases risk of drug-related mortality compared to use of opioids alone
May cause CNS depression, which may impair physical and mental abilities; use caution when performing tasks that require mental alertness
Use caution in patients with hypersensitivity reactions to other phenanthrene derivative opioid agonists including codeine, hydromorphone, morphine, oxymorphone, oxycodone, and levorphanol
May cause dose-related respiratory depression (risk increased in children, elderly, patients with pulmonary disease, and when used postoperatively
Patients with genetic variations of CYP2D6, including poor metabolizers or extensive metabolizers, may have decreased or increased hydromorphone formation
Identify underlying cause of cough before prescribing for cough
Use caution in autonomic neuropathy, brain damage in children, cardiac arrhythmias, chronic lung disease, Down Syndrome, drug abuse/dependence, emotional liability, gallbladder disease, head injury, hepatic impairment, hypertension, hyperthyroidism, increased intracranial pressure, renal impairment, seizures with epilepsy, spastic paralysis in children, toxemia of pregnancy, urethral stricture, urinary tract surgery, xerostomia
Use caution in patients with ischemic heart disease (contraindicated in severe disease), acute abdominal conditions (may obscure diagnosis or clinical course), diabetes mellitus increased intraocular pressure, prostatic hyperplasia and/or GU obstruction, pulmonary disease, adrenal insufficiency, including Addison’s disease, and debilitated patients (greater potential for respiratory depression and therapeutic dosages)
Pseudophedrine
Mild-mod HTN, cardiac disease, hyperthyroidism, hyperglycemia, BPH, DM, glaucoma
Many combo formulations are switching to phenylephrine due to restrictions arising from easy conversion to methamphetamine (The Combat Methamphetamine Epidemic Act of 2005 bans OTC sales of cold medicines that contain ingredients commonly used to make methamphetamine such as pseudoephedrine)
Lactation
Pregnancy and Lactation
Pregnancy category: C
Lactation: enters breast milk; contraindicated
Maximum Dosage
NOTE: Do not exceed recommended dosage limits for the specific product prescribed; the following are general guidelines:
Hydrocodone 20 mg/day PO in combination with pseudoephedrine 240 mg/day PO.
Hydrocodone 20 mg/day PO in combination with pseudoephedrine 240 mg/day PO.
Use is contraindicated.
Use is contraindicated.
Use is contraindicated.
How supplied
Hydrocodone bitartrate/pseudoephedrine hydrochloride
oral liquid: Schedule II
- (5mg/60mg)/5mL